Cargando…

Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is an immunologically and histologically diverse tumor. However, how the structural heterogeneity of tumor microenvironment (TME) affects cancer progression and treatment response remains unclear. Hence, we characterized the TME architectures of cc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Dawei, Ni, Yuanli, Wang, Yongquan, Feng, Juan, Zhuang, Na, Li, Jiatao, Liu, Limei, Shen, Wenhao, Zheng, Ji, Zheng, Wei, Qian, Cheng, Shan, Juanjuan, Zhou, Zhansong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360235/ https://www.ncbi.nlm.nih.gov/pubmed/37474942 http://dx.doi.org/10.1186/s12967-023-04336-8

Ejemplares similares

Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma
por: Xu, Wenhao, et al.
Publicado: (2023)

FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Zhong, Guanghui, et al.
Publicado: (2022)

Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics study
por: Chen, Wen-jin, et al.
Publicado: (2022)

STEAP3 can predict the prognosis and shape the tumor microenvironment of clear cell renal cell carcinoma
por: Wu, Jiyue, et al.
Publicado: (2022)

Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma
por: Wang, Tao, et al.
Publicado: (2022)

Long-Term Evaluation of Patients Undergoing Genitoplasty due to Disorders of Sex Development: Results from a 14-Year Follow-Up
por: Zhang, Heng, et al.
Publicado: (2013)

Protein Arginine Methyltransferases Refine the Classification of Clear Cell Renal Cell Carcinoma with Distinct Prognosis and Tumor Microenvironment Characteristics
por: Ye, Shiqi, et al.
Publicado: (2023)

EDA-E7 Activated DCs Induces Cytotoxic T Lymphocyte Immune Responses against HPV Expressing Cervical Cancer in Human Setting
por: Feng, Juan, et al.
Publicado: (2023)

CGN Correlates With the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Tian, Zijian, et al.
Publicado: (2022)

Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2021)

Predicting prognosis and immunotherapeutic response of clear cell renal cell carcinoma
por: Wang, Jun, et al.
Publicado: (2022)

Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy
por: Zhong, Weimin, et al.
Publicado: (2021)

Effect of MAP3K8 on Prognosis and Tumor-Related Inflammation in Renal Clear Cell Carcinoma
por: Hao, Jiatao, et al.
Publicado: (2021)

Multi-omics profiles refine L-dopa decarboxylase (DDC) as a reliable biomarker for prognosis and immune microenvironment of clear cell renal cell carcinoma
por: Chang, Kun, et al.
Publicado: (2022)

Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape
por: Golkaram, Mahdi, et al.
Publicado: (2022)

Anoikis-related genes signature development for clear cell renal cell carcinoma prognosis and tumor microenvironment
por: Jiang, Yinglei, et al.
Publicado: (2023)

Functional Heterogeneity of Reelin in the Oral Squamous Cell Carcinoma Microenvironment
por: Zhang, Xinwen, et al.
Publicado: (2021)

Identification of the Prognosis Value and Potential Mechanism of Immune Checkpoints in Renal Clear Cell Carcinoma Microenvironment
por: Liao, Guodong, et al.
Publicado: (2021)

Inference on spatial heterogeneity in tumor microenvironment using spatial transcriptomics data
por: Biswas, Antara, et al.
Publicado: (2022)

m(6)A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

Single cell analysis reveals intra‐tumour heterogeneity, microenvironment and potential diagnosis markers for clear cell renal cell carcinoma
por: Zhang, Man, et al.
Publicado: (2022)

The Tumor Microenvironment of Clear-Cell Ovarian Cancer
por: Devlin, Michael-John, et al.
Publicado: (2022)

Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma
por: Fu, Liangmin, et al.
Publicado: (2022)

EMILIN2 is associated with prognosis and immunotherapy in clear cell renal cell carcinoma
por: Zhao, Guangjian, et al.
Publicado: (2022)

Comprehensive Genomic Characterization of Tumor Microenvironment and Relevant Signature in Clear Cell Renal Cell Carcinoma
por: Zhang, Chuanjie, et al.
Publicado: (2022)

Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment
por: Xu, Wenhao, et al.
Publicado: (2021)

A Five Collagen-Related Gene Signature to Estimate the Prognosis and Immune Microenvironment in Clear Cell Renal Cell Cancer
por: Shi, Xiaokai, et al.
Publicado: (2021)

High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma
por: Tang, Yuting, et al.
Publicado: (2022)

Snail heterogeneity in clear cell renal cell carcinoma
por: Zaldumbide, Laura, et al.
Publicado: (2016)

Gene mutation profiling and clinical significances in patients with renal cell carcinoma
por: Wang, Yongquan, et al.
Publicado: (2023)

m7G regulator-mediated molecular subtypes and tumor microenvironment in kidney renal clear cell carcinoma
por: Chen, Mei, et al.
Publicado: (2022)

The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Monjaras-Avila, Cesar U., et al.
Publicado: (2023)

Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil
por: Peng, Haoxin, et al.
Publicado: (2023)

Synthesis and pharmacological evaluation of novel epidermal growth factor receptor inhibitors against prostate tumor cells
por: Zhi, Yi, et al.
Publicado: (2018)

Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
por: Liu, Guohong, et al.
Publicado: (2023)

A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma
por: Gao, Jiahao, et al.
Publicado: (2022)

CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia
por: Liu, Yongliang, et al.
Publicado: (2021)

Prostatic fluid exosome-mediated microRNA-155 promotes the pathogenesis of type IIIA chronic prostatitis
por: Zhao, Baixiong, et al.
Publicado: (2021)

Microenvironment-related gene TNFSF13B predicts poor prognosis in kidney renal clear cell carcinoma
por: Jiang, Mingzhe, et al.
Publicado: (2020)

XYZeq: Spatially resolved single-cell RNA sequencing reveals expression heterogeneity in the tumor microenvironment
por: Lee, Youjin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f7qhd4pm5h9e239lo4okmbtdde